Trials confirm benefits of triple COPD therapy

LONDON – Phase III evidence confirms the multiple benefits of using a triple, fixed-dose combination (FDC) therapy over standard options in patients with severe chronic obstructive pulmonary disease...
Source: Hospitalist News - Category: Hospital Management Source Type: research